Development of a real‐time PCR assay for detection and differentiation of Mycoplasma ovipneumoniae and a novel respiratory‐associated Mycoplasma species in domestic sheep and goats

Abstract

A novel respiratory-associated Mycoplasma species (M. sp. nov.) of unknown clinical significance was recently identified that causes false positive results with multiple published PCR methods reported to specifically detect Mycoplasma ovipneumonaie, a well-known respiratory pathogen in small ruminants. This necessitates our objective to develop a real-time PCR (qPCR) assay for improved specificity and sensitivity, and more rapid detection and differentiation of M. ovipneumoniae and the M. sp. nov. in domestic sheep (DS) and domestic goat (DG) samples, as compared to a conventional PCR and sequencing (cPCR-seq) assay. Primers and probes were designed based on available M. ovipneumoniae 16S rRNA gene sequences in the GenBank database, and partial 16S rRNA gene sequences provided by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS) for M. ovipneumoniae and M. sp. nov. USDA-ARS provided DS (n = 153) and DG (n = 194) nasal swab nucleic acid that previously tested positive for either M. ovipneumoniae (n = 117) or M. sp. nov. (n = 138), or negative for both targets (n = 92) by cPCR-seq. A host 18S rRNA gene was included as an internal control to monitor for the failure of nucleic acid extraction and possible PCR inhibition. For samples positive by cPCR-seq, qPCR agreement was 88.0% (103/117; κ = 0.81) and 89.9% (124/138; κ = 0.84) for M. ovipneumoniae and M.sp. nov., respectively; 12 of 255 (4.7%) cPCR-seq positive samples were qPCR positive for both targets. Of samples negative by cPCR for both mycoplasmas, qPCR detected M. ovipneumoniae and M. sp. nov. in 6.5% (6/92) and 4.3% (4/92), respectively. Samples with discordant results between the cPCR and sequencing assay and the new qPCR were analyzed by target sequencing; successfully sequenced samples had identityThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Investigating the Immunological Activity of the Hsp70-P113 Fusion Protein for Mycoplasma ovipneumoniae Detection: A Groundbreaking Study

“…Pathogen isolation and identi cation are considered the gold standard for Movi detection but are subject to stringent culture conditions, resulting in low isolation rates. In recent years, various molecular biology assays, including PCR, quantitative PCR (qPCR), loop-mediated isothermal ampli cation (LAMP), single-stranded DNA probes, and recombinase polymerase ampli cation (RPA), have been widely used to detect Movi [7][8][9][10][11][12][13]. The detection of antibodies serves as a valuable tool in disease diagnosis, epidemiological investigations, and the assessment of vaccine immunization e cacy.…”

Comparative genomics ofMycoplasma feriruminatoris, a fast-growing pathogen of wildCaprinae

“…The class Mollicutes includes 11 genera (Brown et al, 2018), among which the Mycoplasma genus gathers the largest number of pathogenic or opportunistic species (n=78) and continues to grow as new species are regularly described in various hosts. Six new Mycoplasma species were described in the year 2022 alone (Noll et al, 2022; Spergser et al, 2022; Volokhov et al, 2022). Mycoplasma spp.…”

Comparative genomics of Mycoplasma feriruminatoris, a fast-growing pathogen of wild Caprinae

“…The class Mollicutes includes 11 genera [1], among which the Mycoplasma genus gathers the largest number of pathogenic or opportunistic species ( n =78) and continues to grow as new species are regularly described in various hosts. Six new Mycoplasma species were described in the year 2022 alone [2–4]. Mycoplasma spp .…”